Latest quarter
Estée Lauder reported fiscal first-quarter sales of $3.715 billion, above the consensus estimate of $3.64 billion. Adjusted earnings per share of $0.72 also exceeded the consensus estimate of $0.51.
The company’s filing attributed reported sales growth to fragrance and skin care, with a smaller contribution from makeup. It said fragrance sales rose 19%, led by Le Labo, TOM FORD, Jo Malone London and Estée Lauder, while skin care sales increased 5%, primarily on growth from La Mer and The Ordinary. Hair care sales fell 1%, including the effect of Aveda’s supply-chain logistics challenges.
Diluted earnings per share were $0.64, compared with $0.13 a year earlier. Gross margin rose to 75.7% from 73.4%; the filing cited business mix, pricing and benefits from the Profit Recovery and Growth Plan. CFO Akhil Shrivastava said free cash flow was a use of $235 million, compared with a use of $436 million a year earlier.
| Q1 FY2027 | Q1 FY2026 | Change | |
|---|---|---|---|
| Revenue | $3.7 billion | $3.5 billion | 6.72% |
| Diluted EPS | $0.64 | $0.13 | 389.5% |
| Gross margin | 75.7% | 73.4% | 2.4 percentage points |
| Operating margin | 11.0% | 4.85% | 6.1 percentage points |
| Free cash flow | −$166.0 million | −$436.0 million | — |
| Against the consensus | Reported | Consensus | Result |
|---|---|---|---|
| Adjusted EPS | $0.39 | $0.32 | Beat by 21.9% |
| Revenue | $3.6 billion | $3.6 billion | Beat by 2.15% |
Adjusted EPS is the figure the consensus estimates, not the GAAP EPS above.
What management said on the call
CEO Stéphane de La Faverie said first-quarter organic sales growth spanned categories and regions, with fragrance up 20% and skin care up 4%. He said mainland China organic sales grew 9%, while priority emerging markets grew 15%, led by Turkey, Mexico and India. In makeup, he attributed growth at M·A·C and TOM FORD to innovation across lip, face and eye products.
Discussing fragrance in the Q&A, de La Faverie said the company had increased investment and accelerated product launches while seeking a larger presence in the prestige price tier alongside its luxury portfolio. He said Estée Lauder Glimmer’s start in the U.S. and U.K. gave the company confidence to take it to more markets in the second half. He also said the company gained fragrance share in markets including the U.S., U.K., China, Japan and Korea.
CFO Akhil Shrivastava attributed gross-margin improvement to strategic pricing, procurement savings and manufacturing efficiencies. He said consumer-facing investment rose 8%, including spending on advertising and promotions, while non-consumer-facing expenses fell 1%. Shrivastava said the company still expected the vast majority of the Profit Recovery and Growth Plan’s full run-rate benefits by the end of fiscal 2027.
Asked about the sales outlook, de La Faverie said innovation accounted for 29% of first-quarter sales and was expected to contribute less in the second half; the company still targets 25% for the full year. He also expects less net sales growth in travel retail against a higher prior-year base. Shrivastava said freight and commodity costs were factored into the outlook, alongside restructuring work and contingency planning.
Shrivastava said Estée Lauder completed its acquisition of the remaining interest in Forest Essentials on October 5 and did not expect a material effect on fiscal 2027 consolidated results.
Guidance
Estée Lauder raised its fiscal 2027 organic sales growth outlook to 4% to 5.5% from 3% to 5%. CFO Akhil Shrivastava said adjusted operating margin is now expected to be 12.9% to 13.7%, versus 12.7% to 13.5% previously, and adjusted diluted EPS is expected to be $3.20 to $3.45, versus $3.10 to $3.35.
Shrivastava said operating cash flow is expected to be $1.4 billion to $1.5 billion, up from $1.3 billion to $1.4 billion. He said the outlook assumes no further geopolitical deterioration, including no material impact from the Middle East conflict and stabilization of disruptions in other key EUKEM markets.
| Metric | For | Guide | Previous guide | Change |
|---|---|---|---|---|
| Revenue, Fragrance | FY2027 | Estée Lauder expects Fragrance growth to accelerate in FY2027. | — | — |
| Revenue, Travel Retail | Q2 FY2027 | Estée Lauder expects strong Travel Retail performance to continue in Q2 FY2027. | — | — |
| Revenue, Excluding Travel Retail | FY2027 | Estée Lauder expects growth excluding Travel Retail to accelerate from the first half to the second half of FY2027. | — | — |
| Revenue, Retail | FY2027 | Estée Lauder expects retail sales to continue accelerating quarter over quarter in FY2027. | — | — |
| Revenue growth, Innovation Share of Sales | FY2027 | 25.0% | — | New |
| Operating cash flow | FY2027 | $1.4 billion–$1.5 billion | $1.3 billion–$1.4 billion | Raised |
| EPS, non-GAAP | FY2027 | $3.20–$3.45 | $3.10–$3.35 | Raised |
| Operating margin, non-GAAP | FY2027 | 12.9%–13.7% | 12.7%–13.5% | Raised |
| Revenue growth, Organic Non Gaap | FY2027 | 4.00%–5.50% | — | New |
| Capex growth | FY2027 | 4.00% | 4.00% | Held |
| Tax rate, non-GAAP | FY2027 | 33.0%–34.0% | 33.0%–34.0% | Held |
| Revenue, Eukem | H2 FY2027 | Estée Lauder expects stronger sales growth in EUKEM in the second half of FY2027. | — | — |
| EPS, Non Gaap Constant Currency | FY2027 | $3.16–$3.41 | $3.06–$3.31 | Raised |
| EPS, GAAP | FY2027 | $2.85–$3.18 | $2.52–$2.85 | Raised |
| Revenue growth, non-GAAP | FY2027 | 4.00%–5.50% | 3.00%–5.00% | Raised |
| Capex growth, Percent of Projected Sales | FY2027 | 4.00% | — | New |
| Units, Diluted Weighted Average Shares | FY2027 | 368,000,000 | — | — |
| Operating margin | FY2027 | 12.5%–13.0% | — | New |